IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,888,500 | -14.5% | 50,000 | 0.0% | 0.20% | -14.7% |
Q3 2022 | $2,210,000 | +19.4% | 50,000 | 0.0% | 0.23% | +10.0% |
Q2 2022 | $1,851,000 | -29.6% | 50,000 | -29.6% | 0.21% | -18.9% |
Q1 2022 | $2,630,000 | +14.8% | 71,000 | -5.3% | 0.26% | +70.4% |
Q4 2021 | $2,291,000 | -8.9% | 75,000 | 0.0% | 0.15% | -14.1% |
Q3 2021 | $2,516,000 | -15.9% | 75,000 | 0.0% | 0.18% | -12.8% |
Q2 2021 | $2,992,000 | -11.3% | 75,000 | 0.0% | 0.20% | -13.6% |
Q1 2021 | $3,372,000 | +30.1% | 75,000 | +17.2% | 0.24% | -54.4% |
Q1 2016 | $2,592,000 | -37.5% | 64,000 | -4.5% | 0.52% | -17.9% |
Q4 2015 | $4,149,000 | – | 67,000 | – | 0.63% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |